Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.

UNLABELLED Glucose metabolic activity expressed as (18)F-FDG uptake may be increased in active atherosclerotic plaque. Calcium depositions are often increased in mature atherosclerotic plaque. The purpose of the present study was to assess the patterns of vascular-wall (18)F-FDG uptake and CT calcifications using combined PET/CT. METHODS One hundred twenty-two consecutive patients over the age of 50 (47 women and 75 men; mean age, 66 +/- 9 y) undergoing whole-body (18)F-FDG PET/CT for tumor assessment were retrospectively evaluated. PET, CT, and PET/CT slices were generated for review. Abnormal vascular findings in major arteries in the chest and abdomen were categorized as PET positive (PET+), PET negative (PET-), CT positive (CT+), or CT negative (CT-). The topographic relationship between increased vascular-wall (18)F-FDG uptake on PET and the presence of calcifications on CT was assessed on PET/CT fused images, with abnormal sites further classified as PET+/CT+, PET+/CT-, or PET-/CT+. The presence of CT calcifications and increased vascular-wall (18)F-FDG uptake was correlated with age, sex, presence of cardiovascular risk factors, and cardiovascular disease. RESULTS Abnormal findings were identified at 349 sites. CT calcifications (CT+) were observed at 320 sites (92%) of 100 patients (82%), more commonly in men (P < 0.03), in older patients (P < 0.0001), in patients with hypertension (P < 0.003) or hyperlipidemia (P < 0.04), and in smokers (P < 0.008). Increased vascular-wall (18)F-FDG uptake (PET+) was observed at 52 sites (15%) of 38 patients (31%), more commonly in men (P < 0.02), in older patients (P < 0.0001), and in patients with hypertension (P < 0.02), and was borderline in patients with cardiovascular disease (P = 0.057). PET+ and CT+ findings correlated in 12 patients, a PET+/CT- pattern was found in 18 patients, and 8 patients had increased vascular-wall (18)F-FDG uptake in sites with and without calcifications (PET+/CT+, CT-). Twenty-two patients (18%) had a PET-/CT- pattern. CONCLUSION Hybrid PET/CT can be used to identify and to correctly localize vascular-wall (18)F-FDG activity. Increased vascular-wall (18)F-FDG activity was found in 15% of sites and CT calcifications were noted in 92% of sites, with congruent findings in 7%. The clinical significance of the relationship between vascular-wall (18)F-FDG uptake and CT calcifications needs to be assessed by further prospective studies with long-term follow up.

[1]  A. Kuten,et al.  Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  S. Larson,et al.  Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis. , 2001, Archives of internal medicine.

[3]  A. Alavi,et al.  F-18 FDG Uptake in the Large Arteries: A New Observation , 2001, Clinical nuclear medicine.

[4]  V. Fuster,et al.  Radiotracers for low density lipoprotein biodistribution studies in vivo: technetium-99m low density lipoprotein versus radioiodinated low density lipoprotein preparations. , 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[5]  E Falk,et al.  Techniques characterizing the coronary atherosclerotic plaque: influence on clinical decision making? , 2000, Journal of the American College of Cardiology.

[6]  Yuji Nakamoto,et al.  Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. , 2003, Radiology.

[7]  A. Alavi,et al.  18F FDG uptake in the large arteries: a correlation study with the atherogenic risk factors. , 2002, Seminars in nuclear medicine.

[8]  M. Murphy,et al.  Coronary angiogram interpretation. Interobserver variability. , 1978, JAMA.

[9]  R. Wahl,et al.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG) , 2001, Nuclear medicine communications.

[10]  Michael C. Fishbein,et al.  Histopathologic Validation of Angioscopy and Intravascular Ultrasound , 1991, Circulation.

[11]  V. Fuster,et al.  Atherosclerotic aortic component quantification by noninvasive magnetic resonance imaging: an in vivo study in rabbits. , 2001, Journal of the American College of Cardiology.

[12]  J. Pickard,et al.  Imaging Atherosclerotic Plaque Inflammation With [18F]-Fluorodeoxyglucose Positron Emission Tomography , 2002, Circulation.

[13]  P. Demacker,et al.  Evaluation of indium-111-polyclonal immunoglobulin G to quantitate atherosclerosis in Watanabe heritable hyperlipidemic rabbits with scintigraphy: effect of age and treatment with antioxidants or ethinylestradiol. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  P Toutouzas,et al.  Thermal heterogeneity within human atherosclerotic coronary arteries detected in vivo: A new method of detection by application of a special thermography catheter. , 1999, Circulation.

[15]  V. Fuster,et al.  Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. , 1996, Circulation.

[16]  K. Moser,et al.  Coronary calcium screening in asymptomatic patients as a guide to risk factor modification and stress myocardial perfusion imaging , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[17]  A. Fischman,et al.  Radionuclide imaging of experimental atherosclerosis with nonspecific polyclonal immunoglobulin G. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. Ghesani,et al.  F-18 Fluorodeoxyglucose Uptake in Atherosclerotic Plaque in the Mediastinum Mimicking Malignancy: Another Potential for Error , 2004, Clinical nuclear medicine.

[19]  L. Mortelmans,et al.  Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  V. Fuster,et al.  Atherosclerosis: imaging techniques and the evolving role of nuclear medicine. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[21]  P. Raggi.  Coronary calcium on electron beam tomography imaging as a surrogate marker of coronary artery disease. , 2001, American Journal of Cardiology.

[22]  H Rijsterborgh,et al.  Histopathologic validation of intracoronary ultrasound imaging. , 1994, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[23]  C T Lancée,et al.  Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. , 1989, Journal of the American College of Cardiology.